#069: Beyond Boundaries. Advocacy, Research, and Recognition in MS with Rachel Horne

#069: Beyond Boundaries. Advocacy, Research, and Recognition in MS with Rachel Horne

MS patient and advocate Rachel Horne sponsors a prize for women in MS research and campaigns for more diversity in clinical trials.

You can read all questions and answers on my blog: https://ms-perspektive.com/69-rachel-horne

Rachel Horne was diagnosed with multiple sclerosis at the age of 43, when she felt fit and healthy. She established the Rachel Horne Award to raise the visibility of women in MS research. The selection is made by a number of volunteers from International Women in MS according to clear criteria.

Rachel also advocates for a more diverse group of study participants in clinical trials. This could help to find the right treatment for each individual MS patient, regardless of age, gender, ethnicity or co-morbidities. The greater the diversity of the study population, the better it is possible to assess effects and find out who benefits most and who does not.

Introduction - Who is Rachel Horne?

My name is Rachel. I was born in Canada and have lived in the UK for more than 30 years. I was diagnosed with MS in 2009 – about 15 years ago. I am married and have two adult children. Hobbies – I have to say reading!

Finally, what message of hope or encouragement would you like to share with individuals living with MS?

I think it is so easy to forget that treatment into MS is a neurological success story. We now have over 20 drugs to treat our disease. People are living longer, better lives with the disease. The days of 'diagnose and adios" are gone… though I am aware there are many countries in the world where this is not so.

How and where can interested people find you online?

I am on X (formerly Twitter): @RachelHorne19

---

Thanks to Rachel for all her efforts in making the world more diverse and balanced,

See you soon and try to make the best out of your life,
Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(193)

#191: BTK inhibitors in MS: where do we stand after ECTRIMS/ACTRIMS 2026?

#191: BTK inhibitors in MS: where do we stand after ECTRIMS/ACTRIMS 2026?

BTK inhibitors have produced different results in multiple sclerosis trials. In episode no. 191, I explore what we learned at ECTRIMS/ACTRIMS 2026 about individual medicines, their potential benefits ...

11 Nov 19min

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

https://ms-perspektive.de/en/190-unseen-faces-of-ms/Living with multiple sclerosis often means experiencing symptoms that others cannot see. Austrian artist Gabriela Romagna shares her journey to an M...

4 Nov 32min

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

How could new imaging in MS help us understand progression and develop better treatments? In this episode, I explore key insights from Daniel Reich's MSToronto2026 lecture and related research. Learn ...

28 Okt 15min

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

"Get rid of MS as soon as possible and make ourselves superfluous." — Jan van Amstel What can a stronger European voice achieve for people living with MS? In episode #188, EMSP President Jan van Amste...

21 Okt 31min

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

Aging in multiple sclerosis brings new questions about relapses, gradual progression and treatment choices. In episode 187, Dr. Yi Chao Foong, an MS neurologist and researcher in Tasmania, explains wh...

14 Okt 29min

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

Why can multiple sclerosis progress even when relapses are well controlled? In episode 186, I speak with Prof. Manuel Friese about the next challenge in MS research: protecting nerve cells from damage...

7 Okt 43min

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

An MS diagnosis can depend on where you live, whether you can reach a neurologist and how quickly you can get an MRI. In this episode, Nele speaks with neurologist and neuroimmunologist Dr. Enrique Go...

30 Sep 36min

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

Read the full blog post and interview here: https://ms-perspektive.de/en/184-klaus-schmierer/ How early should MS treatment start, how strongly should we treat, and is there ever a point when it becom...

23 Sep 41min

Populärt inom Utbildning

husmodern-med-amanda-schulman
historiepodden-se
det-skaver
rosceremoni
rss-bara-en-till-om-beroende-medberoende
nu-blir-det-historia
harrisons-dramatiska-historia
rss-viktmedicinpodden
not-fanny-anymore
roda-vita-rosen
rss-dr-bjorklund
i-vantan-pa-katastrofen
allt-du-velat-veta
sektledare
sa-in-i-sjalen
rss-basta-livet
johannes-hansen-podcast
rss-traningsklubben
sektpodden
rss-max-tant-med-max-villman